• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PENUMBRA, INC. POD; HCG, KRD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PENUMBRA, INC. POD; HCG, KRD Back to Search Results
Model Number RBYPOD6
Medical Device Problem Codes Physical Resistance/Sticking (4012); Premature Separation (4045)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 11/18/2021
Type of Reportable Event Malfunction
Event or Problem Description
The patient was undergoing a coil embolization procedure in the right renal artery using pod coils and a non-penumbra microcatheter.During the procedure, the physician successfully placed penumbra coils in the target vessel using the microcatheter.While advancing a pod coil through the microcatheter and into the target location with approximately one centimeter of the pod coil in the microcatheter, the physician experienced resistance and the pod coil became stuck within the microcatheter.Therefore, the physician decided to remove the pod coil.Upon retraction, the pod coil unintentionally detached in the right renal artery.Therefore, the physician used a snare device to successfully remove the detached pod coil.Next, the physician advanced a new pod coil through the microcatheter and into the target location; however, the same issue occurred, and the pod coil became stuck within the microcatheter.Therefore, the physician decided to remove the pod coil.Upon retraction, the pod coil unintentionally detached in the aorta.Therefore, the physician used a snare device to successfully remove the detached pod coil.The procedure was completed using another pod coil and a new microcatheter.There was no report of an adverse effect to the patient.
 
Additional Manufacturer Narrative
The product was not returned for evaluation.Without the return of the device, the root cause of the problem cannot be determined.The manufacturing records for this lot were reviewed and did not reveal any outstanding discrepancies, design, or quality concerns.This report is associated with mfr report number: 3005168196-2022-00001.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
POD
Common Device Name
HCG, KRD
Manufacturer (Section D)
PENUMBRA, INC.
one penumbra place
alameda CA 94502
Manufacturer Contact
veronica farris
one penumbra place
alameda, CA 94502
5107483200
MDR Report Key13180191
Report Number3005168196-2022-00002
Device Sequence Number20267259
Product Code HCG
UDI-Device Identifier00814548013817
UDI-Public00814548013817
Combination Product (Y/N)N
Initial Reporter CountryFR
PMA/510(K) Number
K141134
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 01/06/2022
Report Date (Section F) 01/01/2005
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberRBYPOD6
Device Catalogue NumberRBYPOD6
Device Lot NumberF96675
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Date Report to Manufacturer01/10/2005
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 12/21/2021
Initial Report FDA Received Date01/06/2022
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured03/04/2020
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient Age69 YR
Patient SexFemale
Date Report Sent to FDA01/01/2005
-
-